MSC-Derived Extracellular Vesicles in Tumors and Therapy

Area of Science:

• Cell biology
• Nanomedicine
• Regenerative medicine

Background:

• Exosomes from mesenchymal stem/stroma-like cells (MSCs) are cell-free nanovesicles with regenerative properties.
• MSC-derived exosomes contribute to tissue repair, stem cell niche maintenance, disease treatment, and senescence reduction.
• The therapeutic effects of MSC-exosomes are influenced by their cargo, particularly microRNAs, which vary with MSC tissue origin.

Purpose of the Study:

• To review the dual role of MSC-derived exosomes in tumor development.
• To discriminate between tumor-inhibitory and tumor-supportive effects based on exosome microRNA content.
• To discuss the communication networks between MSCs and cancer cells influencing exosome cargo.

Main Methods:

• Literature review focusing on exosome microRNA content.
• Analysis of MSC-exosome interactions with cancer cells.
• Discrimination of tumor-inhibitory and tumor-supportive exosome functions.

Main Results:

• MSC-derived exosomes can exhibit both tumor-inhibitory and tumor-supportive effects.
• Tumor-associated MSCs produce exosomes with altered cargo, influencing cancer cell behavior.
• MicroRNA content is a critical determinant of exosome function in the tumor microenvironment.

Conclusions:

• MSC-derived exosomes have a context-dependent role in cancer, modulated by their microRNA cargo.
• Understanding exosome content is crucial for harnessing their therapeutic potential in oncology.
• Further research is needed to elucidate the precise mechanisms of MSC-exosome communication in tumors.